About
Xana Smart Neurostimulation is a Swiss-Spanish MedTech company focused on developing smart, non-invasive neurostimulation systems. Founded in April 2021 and based in Courroux, Switzerland, with operations in Spain, Xana aims to modulate brain activity to treat various neurological and neuropsychiatric disorders. Their innovative wearable technology stimulates the vagus nerve to address conditions such as insomnia, chronic pain, depression, anxiety, and more. The company has created a patented, miniaturized wearable device that delivers targeted vagus nerve stimulation. This device works alongside a cloud-based system that collects physiological data to monitor treatment effectiveness and allows for personalized therapy adjustments. Xana's product pipeline includes neurostimulation devices designed for multiple indications, emphasizing non-pharmacological treatment alternatives that are safer and potentially more effective than traditional drug therapies. Xana Smart Neurostimulation is dedicated to providing user-friendly, personalized therapeutic solutions for brain disorders, aiming to enhance clinical outcomes and patient acceptance through their advanced medical technology.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2016
Location
3 Route de la Corniche, Epalinges, Vaud, Switzerland, 1066
